Health Care Fraud Enforcement in the Trump Administration: What In-House Counsel and Compliance Leaders Need to Know
Share
708 Demonbreun Street
Rushmi Bhaskaran, a partner in Ballard Spahr's White Collar Defense and Investigations Group, will speak at the American Health Law Association's Long Term and Post-Acute Care Law and Compliance Conference. Rushmi will be joined in conversation with Janine Valdez—Vice President of Compliance at Genesis HealthCare—on the first day of the conference.
The event description:
Combatting fraud, waste, and abuse in the health care sector remains a central priority for the Trump Administration. In June 2025, the Department of Justice announced the National Health Care Fraud Takedown (the largest health care fraud takedown in history) which charged over 300 individuals in connection with over $14.6 billion in alleged fraud. Drawing from perspectives in enforcement and compliance, this session will explore how the DOJ is targeting misconduct in the health care sector and provide practical guidance for in-house personnel to strengthen internal controls, identify emerging risks, and respond effectively to government inquiries. The session will include:
- Key themes from the DOJ’s 2025 health care fraud takedown, including notable cases that are relevant for LTC facilities
- Methods the DOJ employs to investigate health care fraud cases, including its expanding use of data analytics and reliance on whistleblowers
- DOJ use of the False Claims Act in enforcement of health care anti-fraud priorities
- Strategies for organizational response to inquiries from the DOJ and OIG
- Practical tips and guidance for in-house personnel to navigate the shifting enforcement landscape and implement robust compliance programs to mitigate risks